More on ALMR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.0 Score)

Upcoming Events

- Earnings (8/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(NQ:ALMR)
Delayed: 25.95 +1.00 (4.01%)
Prev. Close $24.95  
Open$24.46 
52 Wk High$ 
52 Wk Low$ 
Day High$26.34 
Day Low$24.15 
P/E N/A  
EPS$ 
Volume245,634 


Jul 15, 2026 04:04 PM Form 8-K Alamar Biosciences, Inc. For: Jul 15
Jul 14, 2026 04:05 PM Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026
Jul 13, 2026 05:43 AM Alamar Biosciences launches national Alzheimer's proteomics study
Jul 13, 2026 02:30 AM Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases
Jul 10, 2026 06:13 AM Alamar Biosciences NULISA data to appear in 140+ AAIC presentations
Jul 10, 2026 06:11 AM Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling
Jul 7, 2026 04:55 PM Form SCHEDULE 13D/A Alamar Biosciences, Inc. Filed by: Sands Capital Life Sciences Pulse Fund II, L.P.
Jul 7, 2026 09:12 AM Alamar Biosciences launches eMTBR-Tau blood test for Alzheimer's
Jul 7, 2026 09:12 AM Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research
Jul 2, 2026 08:46 AM Form SCHEDULE 13G Alamar Biosciences, Inc. Filed by: SHERPA HEALTHCARE FUND II, L.P.
View All Articles

Entities mentioned with ALMR

View All Entities